1-3 of 3
Xuejun Tian
Close
Sort by
Journal Articles

High PD-L1 Expression May be Associated with Worse Overall Prognosis in Acute Myeloid Leukemia

Josette M Kamel, Mendel Goldfinger, Jiani Chai, Jui Choudhuri, Marina Y. Konopleva, Eric J Feldman, Ioannis Mantzaris, Dennis L Cooper, Aditi Shastri, Nishi Shah, Noah Kornblum, Kira Gritsman, Alejandro Sica, Yanhua Wang, Xuejun Tian, Amit Verma, Swati Goel
Journal: Blood
Blood (2023) 142 (Supplement 1): 6050.
https://doi.org/10.1182/blood-2023-188243
Published: 2023
Journal Articles

Oncogenic JAK2/STAT Signaling Molecules Activation Is Associated with PD-L1 Upregulation in Acute Myeloid Leukemia

Jiani Chai, Jui Choudhuri, Qing Wang, Yanan Fang, Yang Shi, Wa Shen, Swati Goel, Ioannis Mantzaris, Aditi Shastri, R. Alejandro Sica, Nishi Shah, Kira Gritsman, Marina Konopleva, Noah Kornblum, Amit Verma, Mendel Goldfinger, Yanhua Wang, Xuejun Tian
Journal: Blood
Blood (2022) 140 (Supplement 1): 6256–6257.
https://doi.org/10.1182/blood-2022-162857
Published: 2022
Journal Articles

Differential Expression of Enhancer of Zeste Homolog 2 (EZH2) Protein in Low and High Grade B-Cell Non-Hodgkin Lymphomas and Differential Regulation of EZH2 Expression By p-ERK and MYC in High Grade B Cell Lymphomas

Xuejun Tian, MD/PhD, Ali Shahsafaei, David M. Dorfman, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2660.
https://doi.org/10.1182/blood.V126.23.2660.2660
Published: 2015